Skip to main content Skip to footer

New strategies for drug discovery and development

Research and development is the lifeblood of every life sciences company and today, companies need to accelerate their discovery efforts. 
Cognizant’s digital solutions are focused on improving your discovery and preclinical processes, and optimizing your product development strategies. Count on us to address the full discovery lifecycle with offerings that include re-engineering and consulting services, lab automation services, biomarker research and knowledge process outsourcing. 
The result is faster drug discovery and better patient outcomes.
Learn more about our Life Sciences solutions for your business.
Re-engineering and consulting
Re-engineering and consulting

Use preclinical processes and IT solutions to reimagine the entire discovery and research value chain.

man pointing at screen
Lab automation
Lab automation

A set of automation solutions that accelerate pharmaceutical research by simplifying operations and reducing manual tasks.

test tubes
Biomarker research
Biomarker research

Our data repositories, marker mining capabilities and pharmacogenomics help in the diagnosis and personalized treatment of diseases.

vial of blood
Decision-support systems
Decision-support systems

The next wave of business analytics is helping to meet customer needs faster than ever. Our decision-support systems include visual mining and informatics-driven drug discovery.

decision support systems
Research tools
Research tools

Advanced research tools such as bioinformatics and chemoinformatics are enabling breakthroughs in areas such as genetic engineering and genomics.

research tools
Knowledge process outsourcing
Knowledge process outsourcing

Take advantage of additional tools like research and competitive intelligence reports and intellectual property reports.

knowledge process outsourcing

Related thinking

Agile drug development required in a new age of urgency

It’s time to reconsider the current paradigm of drug development, clinical trials and regulatory approvals.

vial of blood
The future of infectious disease

For all its horrors, the COVID-19 pandemic may be the agent that takes us to a better place.

AI regulation is coming to life sciences: Three steps to take now

To maximize the value of artificial intelligence and machine learning for patients, healthcare providers together with life sciences enterprises must gear up to meet the continually evolving regulatory landscape.

cell structure


Gaurav Marya

Strategic Business Unit Head & Business Unit Integration Lead, Life Sciences

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.